Jütte, H. J., Reike, M., Wirtz, R. M., Kriegmair, M., Erben, P., Tully, K., . . . Roghmann, F. (2021). KRT20, KRT5, ESR1 and ERBB2 expression can predict pathologic outcome in patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer. Journal of Personalized Medicine, 11(6), . https://doi.org/10.3390/jpm11060473
Chicago-Zitierstil (17. Ausg.)Jütte, Hendrik Jan, et al. "KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer." Journal of Personalized Medicine 11, no. 6 (2021). https://doi.org/10.3390/jpm11060473.
MLA-Zitierstil (9. Ausg.)Jütte, Hendrik Jan, et al. "KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer." Journal of Personalized Medicine, vol. 11, no. 6, 2021, https://doi.org/10.3390/jpm11060473.